The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1

Medicine

Presse/Média: Research

Périodenov. 2 2021

Couverture média

1

Couverture média

  • TitreThe tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1
    Nom du médiaMOLECULAR CANCER
    Pays/TerritoireUnited Kingdom
    Date11/2/21
    PersonnesGregory D. Fairn
Voir tout 1
Afficher moins de contenu